Full View

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

Y Gong, Y Lv, H Liu, Q Zheng… - Therapeutic Advances in …, 2022 - journals.sagepub.com
Objective: This study aimed to quantitatively compare the efficacy and safety of long-acting
β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations …
被引用次数：15 相关文章

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD.

Y Gong, Y Lv, H Liu, Q Zheng… - Therapeutic Advances in …, 2022 - search.ebscohost.com
Objective: This study aimed to quantitatively compare the efficacy and safety of long-acting
β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations …
[HTML] nih.gov

[HTML][HTML] Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

Y Gong, Y Lv, H Liu, Q Zheng, L Li - Therapeutic Advances in …, 2022 - ncbi.nlm.nih.gov
Objective: This study aimed to quantitatively compare the efficacy and safety of long-acting
β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations …

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD.

Y Gong, Y Lv, H Liu, Q Zheng, L Li - Therapeutic Advances in …, 2022 - europepmc.org
Objective This study aimed to quantitatively compare the efficacy and safety of long-acting
β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations …

Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

Y Gong, Y Lv, H Liu, Q Zheng… - … advances in respiratory …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective This study aimed to quantitatively compare the efficacy and safety of long-acting
β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations …